Gastroparesis Overview
Learn About Gastroparesis
Imagine eating just a few bites of a meal and feeling uncomfortably full, followed by hours of nausea, bloating, and upper abdominal pain. For individuals living with gastroparesis, this is a frustrating and often debilitating daily reality. Gastroparesis, which literally means “stomach paralysis,” is a disorder where the stomach takes too long to empty its contents into the small intestine, despite there being no physical blockage. This delay can lead to a host of distressing symptoms and can significantly impact a person’s nutrition and quality of life. Because its symptoms are common and initial tests are often normal, it is frequently misdiagnosed, leaving patients feeling unheard and misunderstood. Understanding this complex condition is the first step toward getting a correct diagnosis and developing a comprehensive management plan.
Gastroparesis is a disorder of gastric motility, meaning it is a problem with the coordinated muscle movement of the stomach. In a healthy digestive system, the stomach performs two main jobs after you eat a meal:
- It churns and grinds the food, mixing it with acid to begin digestion.
- Once the food is properly broken down into a liquid mixture, the strong, coordinated muscular contractions of the stomach wall (peristalsis) propel the food out through the pyloric sphincter and into the small intestine.
This entire process is controlled by the vagus nerve, a major nerve that carries signals from the brain to the digestive system. In gastroparesis, the problem lies either with the stomach muscles themselves or, more commonly, with damage to the vagus nerve. When the vagus nerve is damaged, the signals telling the stomach muscles to contract and empty are disrupted. The stomach loses its ability to effectively grind food and push it into the small intestine.
A helpful analogy is to think of your stomach as a powerful cement mixer:
- Its job is to receive ingredients (food), churn them with liquid (acid), and then, when the mixture is ready, a powerful motor (the stomach muscles), controlled by a main electrical cable (the vagus nerve), opens a gate and forcefully pushes the contents out.
- In gastroparesis, this electrical cable is damaged or cut. The motor may still churn weakly, but the powerful “push-out” signal never arrives.
- As a result, the food sits in the mixer for hours, stagnating and fermenting. This is what causes the symptoms of profound fullness, bloating, nausea, and vomiting undigested food long after a meal.
It is crucial to understand that gastroparesis is a functional disorder, not a structural problem. There is no physical blockage, like a tumor or an ulcer, preventing food from leaving the stomach. The problem is that the stomach’s emptying mechanism is paralyzed or slowed.
Gastroparesis occurs when the stomach muscles fail to contract effectively, most often because of damage to the vagus nerve. This nerve is critical for sending signals that control stomach emptying, so when it is injured or weakened, food remains in the stomach too long. Several conditions can cause this damage, including diabetes, surgery, infections, and certain neurological or autoimmune disorders. In many cases, identifying the underlying cause is key to guiding treatment and management.
- Diabetes mellitus: This is the most common identifiable cause of gastroparesis. Over time, high blood sugar levels can damage nerves throughout the body (neuropathy). When this damage affects the vagus nerve, it results in diabetic gastroparesis.
- Idiopathic gastroparesis: “Idiopathic” means the cause is unknown. Many cases are thought to follow a viral illness that directly damages the vagus nerve.
- Post-surgical gastroparesis: The vagus nerve can be unintentionally injured or severed during certain types of upper abdominal or esophageal surgery.
- Medications: Opioids, some antidepressants, and other drugs that slow gut motility can contribute.
- Autoimmune and connective tissue diseases: Conditions like scleroderma can interfere with gastric motility.
- Neurological conditions: Parkinson’s disease and multiple sclerosis have been associated with gastroparesis.
Primary risk factors include:
- Long-standing or poorly controlled type 1 or type 2 diabetes
- Prior stomach or esophageal surgery
- History of viral illness
- Connective tissue diseases
- Neurological disorders
Gastroparesis develops when the vagus nerve or stomach muscles lose their ability to coordinate contractions needed for emptying. High blood sugar damages nerve cells and reduces nitric oxide production, impairing smooth muscle relaxation. Post-viral immune responses may injure nerve fibers. Surgical injury can interrupt vagus signaling pathways. Regardless of the cause, the result is delayed gastric emptying, leading to stagnation of food in the stomach, poor mixing with gastric acid, and unpredictable emptying into the small intestine.
Gastroparesis is considered relatively rare, but its true prevalence is likely underreported because of frequent misdiagnosis. Studies estimate:
- About 2% of the general population may have gastroparesis-like symptoms.
- Among people with diabetes, prevalence may be as high as 5–12%.
- It is more common in women than men, with some studies suggesting up to 70–80% of cases occur in females.
- Many cases are diagnosed between the ages of 30 and 60, though it can occur at any age.
The signs and symptoms of gastroparesis come from food lingering in the stomach far longer than normal. This delay leads to discomfort, nausea, and a sense of early fullness after only a few bites. In some individuals, symptoms are mild and sporadic, while in others they are persistent and severely affect daily life. The intensity often varies with diet and underlying health conditions.
Common symptoms include:
- Chronic nausea and vomiting, often of undigested food eaten hours earlier
- Early satiety (feeling full after only a few bites)
- Abdominal bloating and distension
- Epigastric pain or discomfort
- Heartburn or gastroesophageal reflux (GERD)-like symptoms
- Fluctuating blood sugar levels in people with diabetes
- Unintentional weight loss and malnutrition
These symptoms often worsen after eating high-fat or high-fiber meals, which naturally slow gastric emptying.
Diagnosing gastroparesis is often challenging and involves a combination of exclusion and confirmation tests.
- Excluding mechanical obstruction:
- Upper endoscopy (EGD): Used to rule out ulcers, tumors, or narrowing at the stomach outlet. Gastroparesis patients may show retained food despite fasting.
- Imaging tests (CT or MRI): Can help exclude obstructions or other conditions.
- Confirming delayed gastric emptying:
- Gastric emptying scintigraphy: Gold standard test. The patient eats a standardized meal with a safe radioactive tracer. Scans at 1, 2, and 4 hours measure stomach emptying. Retaining more than 10% of food at 4 hours confirms gastroparesis.
- Breath testing (13C-octanoic acid breath test): Measures byproducts of meal digestion in exhaled breath.
- SmartPill capsule test: A swallowable device that transmits data on pH, pressure, and temperature as it travels through the GI tract.
Differential diagnosis for Gastroparesis
Because its symptoms overlap with other conditions, several disorders must be ruled out before confirming gastroparesis:
- Peptic ulcer disease
- Functional dyspepsia
- Gastroesophageal reflux disease (GERD)
- Mechanical gastric outlet obstruction (from tumors or strictures)
- Irritable bowel syndrome (IBS)
- Chronic pancreatitis
- Eating disorders (such as anorexia nervosa or bulimia)
There is currently no cure for gastroparesis. Management focuses on symptom control, maintaining nutrition, and improving quality of life.
1. Dietary modifications
- Eat small, frequent meals (4–6 per day)
- Choose low-fat, low-fiber foods
- Opt for soft, pureed, or liquid meals (soups, smoothies, shakes)
- Chew food thoroughly
2. Medications
- Antiemetics: Ondansetron, promethazine, and other medications may help control nausea and vomiting.
- Prokinetics:
- Metoclopramide: FDA-approved for diabetic gastroparesis; limited use due to risk of tardive dyskinesia.
- Erythromycin: Stimulates gastric contractions but effectiveness declines with long-term use.
- Domperidone: Used outside the U.S.; improves motility with fewer central nervous system side effects.
3. Blood sugar management
For people with diabetes, optimizing blood sugar control is critical. Continuous glucose monitors and insulin pumps may help match insulin delivery to unpredictable absorption.
4. Advanced and surgical procedures
- Feeding tubes (J-tube): Directly deliver nutrition into the small intestine.
- Gastric electrical stimulator: Surgically implanted device delivering mild electrical pulses to control nausea and vomiting.
- G-POEM (gastric peroral endoscopic myotomy): Minimally invasive endoscopic procedure that cuts the pylorus muscle to enhance gastric emptying.
If untreated or poorly managed, gastroparesis can lead to significant complications, including:
- Severe malnutrition and unintended weight loss
- Recurrent dehydration from chronic vomiting
- Erratic blood sugar levels in diabetics, increasing risk of complications like hypoglycemia or ketoacidosis
- Formation of bezoars (hardened masses of undigested food in the stomach)
- Reduced quality of life, including anxiety and depression linked to chronic illness
Gastroparesis is a chronic condition. Prognosis varies depending on the cause and severity:
- Diabetic gastroparesis often persists but may improve with tight blood sugar control.
- Post-viral cases sometimes resolve over months to years.
- Idiopathic and severe cases may be lifelong but manageable with lifestyle adjustments, medications, and advanced therapies.
While not all cases can be prevented, there are practical ways to reduce risk. People with diabetes can lower their chances by keeping blood sugar under good control, while others may avoid triggers like certain medications. Seeking medical attention early for unexplained digestive symptoms can also help prevent complications. In short, proactive management may reduce the likelihood or severity of gastroparesis.
- Tight blood sugar control in people with diabetes
- Avoiding medications that slow stomach emptying when possible
- Seeking medical attention for persistent nausea, vomiting, or unexplained fullness after eating
- Early treatment of viral or autoimmune conditions that could affect the GI tract
Living with gastroparesis requires daily adjustments and ongoing support from healthcare providers. Many people find that working closely with a dietitian, gastroenterologist, or endocrinologist helps them navigate challenges. Emotional support from family, friends, or support groups also plays a key role in coping with the condition. Practical strategies include:
- Working with a dietitian to create individualized meal plans
- Keeping a food diary to identify trigger foods
- Staying hydrated with electrolyte-rich fluids
- Using meal replacement shakes or nutritional supplements when solid food is poorly tolerated
- Practicing stress management, as anxiety can worsen symptoms
- Joining support groups for encouragement and shared experiences
Gastroparesis is a debilitating chronic disorder that can severely disrupt a person’s life, turning the simple act of eating into a source of discomfort and distress. It is caused by delayed stomach emptying due to impaired motility, often from diabetes, viral illness, or surgery. While the diagnostic journey can be long, definitive tests like gastric emptying scintigraphy can confirm the condition. There is no cure, but dietary adjustments, medications, and advanced therapies can significantly improve symptoms and quality of life. With proper medical guidance, emotional support, and daily self-management strategies, many individuals can find ways to live fully despite gastroparesis.
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK). (2018). Gastroparesis. Retrieved from https://www.niddk.nih.gov/health-information/digestive-diseases/gastroparesis
- American College of Gastroenterology (ACG). (2022). Gastroparesis. Retrieved from https://gi.org/topics/gastroparesis/
- International Foundation for Gastrointestinal Disorders (IFFGD). (2021). Gastroparesis. Retrieved from https://iffgd.org/gi-disorders/gastroparesis/
- Camilleri M, Parkman HP, Shafi MA, Abell TL, Gerson L. (2013). Clinical guideline: management of gastroparesis. Am J Gastroenterol, 108(1):18–37.
- Hasler WL. (2020). Gastroparesis: pathogenesis, diagnosis, and management. Nat Rev Gastroenterol Hepatol, 17(8):459–473.
MD Anderson
Mehnaz Shafi is a Gastroenterologist in Houston, Texas. Dr. Shafi is rated as an Elite provider by MediFind in the treatment of Gastroparesis. Her top areas of expertise are Gastroparesis, Gastric Dysmotility, Barrett Esophagus, Colonoscopy, and Endoscopy.
South Pointe Medical Office Building B
Michael Cline is a Gastroenterologist in Warrensville Heights, Ohio. Dr. Cline has been practicing medicine for over 40 years and is rated as an Elite provider by MediFind in the treatment of Gastroparesis. His top areas of expertise are Gastroparesis, Gastric Dysmotility, Chronic Idiopathic Constipation (CIC), Gastrectomy, and Ileostomy.
Cleveland Clinic Main Campus
Matthew Kroh is a General Surgeon in Cleveland, Ohio. Dr. Kroh has been practicing medicine for over 29 years and is rated as an Elite provider by MediFind in the treatment of Gastroparesis. His top areas of expertise are Gastroparesis, Hiatal Hernia, Obesity, Gastrectomy, and Gastric Bypass.
Summary: The purpose of this program is to allow the use of domperidone in children from 12 to 21 years of age with symptoms related to motility disorders and Gastroesophageal reflux disease (GERD) who have failed all the standard treatments for their condition.
Summary: The goal of this clinical trial is to evaluate if the study drug CIN-102 (deudomperidone) can help to decrease nausea severity associated with idiopathic gastroparesis severity in adult subjects. The main questions it aims to answer are: * To evaluate the efficacy of CIN-102 on symptoms of gastroparesis when given to patients with idiopathic gastroparesis compared to a placebo * To evaluate the sa...

